<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://sti.bmj.com">
<title>Sexually Transmitted Infections recent issues</title>
<link>http://sti.bmj.com</link>
<description>Sexually Transmitted Infections RSS feed -- recent issues</description>
<prism:publicationName>Sexually Transmitted Infections</prism:publicationName>
<prism:issn>1368-4973</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/89/4/273?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/89/4/274?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/89/4/276?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/89/4/280?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/89/4/285?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/89/4/290?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/89/4/295?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/89/4/301?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/89/4/303?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/89/4/304?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/89/4/305?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/89/4/307?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/89/4/308?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/89/4/310?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/89/4/311?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/89/4/320?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/89/4/327?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/89/4/330?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/89/4/333?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/89/4/336?rss=1" />
  <rdf:li rdf:resource="http://sti.bmj.com/cgi/content/short/89/4/340?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://sti.bmj.com/site/homepage/STI_95x60.gif" />
</channel>
<image rdf:about="http://sti.bmj.com/site/homepage/STI_95x60.gif">
<title>Sexually Transmitted Infections</title>
<url>http://sti.bmj.com/site/homepage/STI_95x60.gif</url>
<link>http://sti.bmj.com</link>
</image>
<item rdf:about="http://sti.bmj.com/cgi/content/short/89/4/273?rss=1">
<title><![CDATA[Highlights from this issue]]></title>
<link>http://sti.bmj.com/cgi/content/short/89/4/273?rss=1</link>
<description><![CDATA[ <sec> <p>You'll see that this is a very special issue. We have brought together two mini-themed issues, both reflecting on social, legal and ethical issues of wide interest. David Gurnham of the University of Southampton is leading a series of seminars, funded by the UK's Economic and Social Research Council on &lsquo;Criminalising Contagion&rsquo; which some of our readers may have attended. We are delighted that he is Guest Editing a series on this topic. We present some research papers which will encourage deeper understanding and wider discussion of emerging political and legal debates about criminalisation. Gurnham's introductory editorial<cross-ref type="bib" refid="R1">1</cross-ref> reflects on the papers presented here, which form part of a wider series co-hosted by sister BMJ Publishing journals, the <I>Journal of Medical Ethics</I>, and <I>Medical Humanities.</I></p> <p>I am also grateful to Nicola Low, Deputy Editor, for commissioning a collection which reflects on the lessons of the Guatemala syphilis...]]></description>
<dc:creator><![CDATA[Cassell, J. A.]]></dc:creator>
<dc:date>2013-05-17T00:44:44-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2013-051188</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2013-051188</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:subject><![CDATA[Drugs: infectious diseases, HIV/AIDS, Adolescent health, Child health, HIV / AIDS, Syphilis, HIV infections, Sex workers, Competing interests (ethics)]]></dc:subject>
<dc:title><![CDATA[Highlights from this issue]]></dc:title>
<prism:publicationDate>2013-06-01</prism:publicationDate>
<prism:section>Whistlestop tour</prism:section>
<prism:volume>89</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>273</prism:startingPage>
<prism:endingPage>273</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/89/4/274?rss=1">
<title><![CDATA[Criminalising contagion: ethical, legal and clinical challenges of prosecuting the spread of disease and sexually transmitted infections]]></title>
<link>http://sti.bmj.com/cgi/content/short/89/4/274?rss=1</link>
<description><![CDATA[ <p>It gives me great pleasure to introduce this special collection of papers on the theme of the criminalisation of infection and disease. The four articles selected here for <I>Sexually Transmitted Infections</I>, which I have had the privilege of editing in collaboration with Professor Jackie Cassell, form part of a larger response across three BMJ Group journals involving also the <I>Journal of Medical Ethics</I> and <I>Medical Humanities</I>, in which similar themed sections will appear in December. The collection represents part of a wider project that brings together healthcare professionals and academic scholars in the fields of public health, medical law and ethics, criminal law and criminal justice, for a series of seminars currently ongoing and funded by the Economic and Social Research Council, in which readers of this journal are invited to participate.<cross-ref type="bib" refid="R1">1</cross-ref></p> <p>Something that the articles collected here may be taken to suggest is that, while the...]]></description>
<dc:creator><![CDATA[Gurnham, D.]]></dc:creator>
<dc:date>2013-05-17T00:44:44-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2013-051156</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2013-051156</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:title><![CDATA[Criminalising contagion: ethical, legal and clinical challenges of prosecuting the spread of disease and sexually transmitted infections]]></dc:title>
<prism:publicationDate>2013-06-01</prism:publicationDate>
<prism:section>Editorial</prism:section>
<prism:volume>89</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>274</prism:startingPage>
<prism:endingPage>275</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/89/4/276?rss=1">
<title><![CDATA[Imprisonment for non-intentional transmission of HIV: can it be supported using established principles for justifying criminal sentencing?]]></title>
<link>http://sti.bmj.com/cgi/content/short/89/4/276?rss=1</link>
<description><![CDATA[
<p>In England, Wales and Scotland, those who unintentionally transmit HIV through sexual intercourse are at risk of criminal prosecution, and furthermore may be at risk of imprisonment under the Offences Against the Person Act 1861. These sentences have ranged between 1 and 10&nbsp;years. There has been a long debate on whether this is an acceptable use of the law, and indeed whether those who transmit HIV in this manner should be subjected to legal proceedings. Previous debate has embraced the rhetoric of shared responsibility and public health. In this paper, we wished instead to apply traditional justifications for sentencing (including retribution, deterrence, rehabilitation, incapacitation and reparation) to imprisonment for non-intentional transmission of HIV through consensual sexual intercourse. We argue that when these principles are applied to imprisonment for this &lsquo;crime&rsquo;, we are unable to justify imprisonment sufficiently, and therefore, that imprisonment is a misguided response to HIV transmission.</p>
]]></description>
<dc:creator><![CDATA[Phillips, M., Sukthankar, A.]]></dc:creator>
<dc:date>2013-05-17T00:44:44-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2012-050978</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2012-050978</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:subject><![CDATA[Drugs: infectious diseases, HIV/AIDS, HIV / AIDS, HIV infections, Health education]]></dc:subject>
<dc:title><![CDATA[Imprisonment for non-intentional transmission of HIV: can it be supported using established principles for justifying criminal sentencing?]]></dc:title>
<prism:publicationDate>2013-06-01</prism:publicationDate>
<prism:section>Behaviour</prism:section>
<prism:volume>89</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>276</prism:startingPage>
<prism:endingPage>279</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/89/4/280?rss=1">
<title><![CDATA[Female sex workers incarcerated in New York City jails: prevalence of sexually transmitted infections and associated risk behaviors]]></title>
<link>http://sti.bmj.com/cgi/content/short/89/4/280?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>Sexually transmitted infections (STIs) are an important cause of morbidity among incarcerated women and female sex workers (FSW). Little is known about FSW incarcerated in New York City (NYC) jails. We reviewed jail health records to identify the STI and HIV prevalence among newly incarcerated FSW in NYC jails. We also examined the relationship of demographics and self-reported clinical and risk behaviour history with FSW status and compared FSW with non-FSW incarcerated women to identify FSW predictors and, guide NYC jail programme planning and policy.</p>
</sec>
<sec><st>Methods</st>
<p>We retrospectively reviewed routinely collected jail health record data to identify the prevalence of chlamydia (Ct), gonorrhoea (Ng) and HIV infection among women newly incarcerated in NYC jails in 2009&ndash;2010 (study period) and studied the relationship of STIs, demographics and self-reported clinical and risk behaviour history with FSW status.</p>
</sec>
<sec><st>Results</st>
<p>During the study period, 10&nbsp;828 women were newly incarcerated in NYC jails. Of these, 10&nbsp;115 (93%) women were tested for Ct and Ng; positivity was 6.2% (95% CI 5.7% to 6.7%) and 1.7% (95% CI 1.4% to 1.9%), respectively. Nine percent had HIV infection. Seven hundred (6.5%) were defined as FSW. FSW were more likely to have Ct (adjusted OR (AOR): 1.55; 95% CI 1.17 to 2.05; p&lt;0.0001) but not Ng or HIV. FSW were more likely to report age 20&ndash;24&nbsp;years, reside in boroughs other than Manhattan, &ge;6 prior incarcerations, &ge;2 incarcerations during the study period, condom use with current sex partners, multiple sex partners and current drug use.</p>
</sec>
<sec><st>Conclusions</st>
<p>Women incarcerated in NYC jails had high rates of Ct, Ng, and HIV infection. FSW were at higher risk for Ct than non-FSW incarcerated women. These findings are being used to design targeted interventions to identify FSW, provide clinical and preventive services in jail and coordinate care with community partners.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Parvez, F., Katyal, M., Alper, H., Leibowitz, R., Venters, H.]]></dc:creator>
<dc:date>2013-05-17T00:44:44-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2012-050977</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2012-050977</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, Open access, Drugs: infectious diseases, HIV/AIDS, Reproductive medicine, Condoms, HIV / AIDS, Gonorrhoea, HIV infections, Sex workers]]></dc:subject>
<dc:title><![CDATA[Female sex workers incarcerated in New York City jails: prevalence of sexually transmitted infections and associated risk behaviors]]></dc:title>
<prism:publicationDate>2013-06-01</prism:publicationDate>
<prism:section>Epidemiology</prism:section>
<prism:volume>89</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>280</prism:startingPage>
<prism:endingPage>284</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/89/4/285?rss=1">
<title><![CDATA['The intention may not be cruel... but the impact may be': understanding legislators' motives and wider public attitudes to a draft HIV Bill in Malawi]]></title>
<link>http://sti.bmj.com/cgi/content/short/89/4/285?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>The law in relation to HIV has prominence in the formation and regulation of moral norms&mdash;in regard to human rights, and in regard to criminalisation, the policing of sexuality and intimate behaviours, and the production of stigma. The research focuses on the potential and impotence of the law to govern for, and enable, the human right to health in the context of HIV in Malawi.</p>
</sec>
<sec><st>Methods</st>
<p>This one-country qualitative case study (Malawi) action research involved data collection during a 6-month period (October 2010&ndash;March 2011). Datasets include interviews with law commissioners (n=10), opinion leaders (n=22), life story participants who were people living with and closely affected by HIV (n=20), reflections of the action research team (n=6), and a review of the proposed HIV and AIDS (Prevention and Management) Bill, legal and policy documents.</p>
</sec>
<sec><st>Results</st>
<p>The analysis of the perspectives of the law commissioners, who formed the Special Law Commission and drafted the Bill, revealed that stigma was consciously invoked to delineate social norms and guide governance of notions of personal responsibility. The analysis of the perspectives of the life story participants, whose lives would be most directly impacted if these provisions came into force, reveals the extent to which the stigma associating criminality and HIV is falling on fertile ground through its engagement and generation of internalised stigma; unearthing an uneasy link between stigma and the law in response to HIV in Malawi.</p>
</sec>
<sec><st>Discussion</st>
<p>The results indicated that the proposed HIV Bill in Malawi manifests a tension between intention and impact. By incorporating criminal sanctions as part of the proposed HIV Bill, the lawmakers actively seek to use stigma to shape social attitudes and attempt to guide normative behaviour.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Stackpool-Moore, L., Kamkwamba, Kampango, Kundecha, Kumwenda, Trapence]]></dc:creator>
<dc:date>2013-05-17T00:44:44-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2012-050976</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2012-050976</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:subject><![CDATA[Drugs: infectious diseases, HIV/AIDS, Sexual and gender disorders, HIV / AIDS, Sexual and gender disorders, Sexual dysfunction, HIV infections, Human rights]]></dc:subject>
<dc:title><![CDATA['The intention may not be cruel... but the impact may be': understanding legislators' motives and wider public attitudes to a draft HIV Bill in Malawi]]></dc:title>
<prism:publicationDate>2013-06-01</prism:publicationDate>
<prism:section>Behaviour</prism:section>
<prism:volume>89</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>285</prism:startingPage>
<prism:endingPage>289</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/89/4/290?rss=1">
<title><![CDATA[Criminal prosecution of a male partner for sexual transmission of infectious diseases: the views of educated people living in Togo]]></title>
<link>http://sti.bmj.com/cgi/content/short/89/4/290?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To examine the views of educated people in Togo on the acceptability of criminal prosecution of a male partner for sexual transmission of infectious diseases (STIDs) to his female partner.</p>
</sec>
<sec><st>Methods</st>
<p>199 adults living in Kara, Togo judged acceptability of criminal prosecution for STID in 45 scenarios composed of combinations of five factors: (a) severity of disease; (b) awareness and communication of one's serological status; (c) partners&rsquo; marital status; (d) number of sexual partners the female partner has and (e) male partner's subsequent attitude (supportive or not).</p>
</sec>
<sec><st>Results</st>
<p>Acceptability was lower (a) when the male partner decided to take care of his female partner he had infected than when he decided to leave, (b) when both partners were informed but decided not to take precautions than when none of them was informed or when only the male partner was informed and (c) when the female partner has had several male sexual partners than when she has had only one. Two qualitatively different views were identified. For 66% of participants, when the male partner accepts to take care of his partner, he should not be sued, except when he did not disclose his serological status. For 34%, when both partners were informed, the male partner should not be sued, irrespective of other circumstances.</p>
</sec>
<sec><st>Conclusions</st>
<p>Regarding criminal prosecution for STID, most people in the sample endorsed the position of the Joint United Nations Programme on HIV/AIDS that urges governments not to apply criminal law to cases where sexual partners disclosed their status or were not informed of it.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Kpanake, L., Patassi, A., Mullet, E.]]></dc:creator>
<dc:date>2013-05-17T00:44:44-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2012-050964</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2012-050964</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:subject><![CDATA[Drugs: infectious diseases, HIV/AIDS, HIV / AIDS, HIV infections]]></dc:subject>
<dc:title><![CDATA[Criminal prosecution of a male partner for sexual transmission of infectious diseases: the views of educated people living in Togo]]></dc:title>
<prism:publicationDate>2013-06-01</prism:publicationDate>
<prism:section>Behaviour</prism:section>
<prism:volume>89</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>290</prism:startingPage>
<prism:endingPage>294</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/89/4/295?rss=1">
<title><![CDATA[Ethics gone awry: the US Public Health Service studies in Guatemala; 1946-1948]]></title>
<link>http://sti.bmj.com/cgi/content/short/89/4/295?rss=1</link>
<description><![CDATA[ <p>In October 2010, the public became aware of a massive clinical research enterprise on sexually transmitted infections, conducted in Guatemala during 1946&ndash;1948.<cross-ref type="bib" refid="R1">1</cross-ref> As the story unfolded it became very clear that the conduct of the studies was clouded by egregious ethical violations. The revelations prompted an official apology by the US Secretary of State Hilary Clinton to the Government of Guatemala, and a subsequent investigation by the Presidential Commission for the Study of Bioethical Issues, resulting in a final report that was issued in September 2011.<cross-ref type="bib" refid="R2">2</cross-ref></p> <p>The archival materials for the Guatemala studies were discovered inadvertently by Dr Susan Reverby, a historian at Wellesley College, whose work has focused on the infamous Tuskegee studies of untreated syphilis, which occurred from the late 1930s through 1972. Reverby's work focused primarily on experiential history, from the view point of the research subjects, of the health professionals who...]]></description>
<dc:creator><![CDATA[Zenilman, J. M.]]></dc:creator>
<dc:date>2013-05-17T00:44:44-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2012-050741</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2012-050741</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:title><![CDATA[Ethics gone awry: the US Public Health Service studies in Guatemala; 1946-1948]]></dc:title>
<prism:publicationDate>2013-06-01</prism:publicationDate>
<prism:section>Editorial</prism:section>
<prism:volume>89</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>295</prism:startingPage>
<prism:endingPage>300</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/89/4/301?rss=1">
<title><![CDATA[Will the STI studies in Guatemala be remembered, and for what?]]></title>
<link>http://sti.bmj.com/cgi/content/short/89/4/301?rss=1</link>
<description><![CDATA[ <p>Every few years another medical research story breaks in the media with all the <I>schadenfreude</I> of a bad Grade B movie. These melodramas are full of arrogant, imperial and/or racist doctors with science gleaming in their eyes, helpless uniformed subjects usually of colour purportedly grateful for the attention, and an under-resourced area of the USA or another country in the starring roles. The latest big report came in 2010<cross-ref type="bib" refid="R1">1</cross-ref> when news of the 1940s sexually transmitted infection's study in Guatemala appeared with all its grisly details and photographic evidence.<cross-ref type="bib" refid="R2">2</cross-ref> When knowledge of the unpublished and never cited study became known, the federal government at the highest levels apologised to Guatemala, the presidential bioethics commission wrote and publicised a damning report, the Guatemalan government condemned the study in their own report, and the heads of the National Institutes of Health (NIH) and Centers for Disease Control...]]></description>
<dc:creator><![CDATA[Reverby, S. M.]]></dc:creator>
<dc:date>2013-05-17T00:44:44-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2013-051115</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2013-051115</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:title><![CDATA[Will the STI studies in Guatemala be remembered, and for what?]]></dc:title>
<prism:publicationDate>2013-06-01</prism:publicationDate>
<prism:section>Editorial</prism:section>
<prism:volume>89</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>301</prism:startingPage>
<prism:endingPage>302</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/89/4/303?rss=1">
<title><![CDATA[Principles, progress and harm in the Guatemala Syphilis Study]]></title>
<link>http://sti.bmj.com/cgi/content/short/89/4/303?rss=1</link>
<description><![CDATA[ <p>The discovery of Dr Cutler's studies in Guatemala is significant for a number of reasons, of which I would like to highlight just two. Historically, the documents represent important evidence about the development of the concepts of bodily integrity and rights. The article asks whether we are entitled to judge practices that took place over 60&nbsp;years ago: were the norms not different then? Should we not take account of the fact that in those days a different culture existed, with different expectations about individuals&rsquo; rights? However, arguments about historical and cultural relativism require caution, and it is clear from the brief extracts from Dr Cutler's correspondence&mdash;in which he worries about the need for secrecy and that adverse public exposure could lead to the forced closure of operations&mdash;that we cannot excuse him by way of simple cultural and historical difference.</p> <p>Second, the papers provide an opportunity to reflect on current...]]></description>
<dc:creator><![CDATA[Gurnham, D.]]></dc:creator>
<dc:date>2013-05-17T00:44:44-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2013-051113</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2013-051113</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:title><![CDATA[Principles, progress and harm in the Guatemala Syphilis Study]]></dc:title>
<prism:publicationDate>2013-06-01</prism:publicationDate>
<prism:section>Commentary</prism:section>
<prism:volume>89</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>303</prism:startingPage>
<prism:endingPage>303</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/89/4/304?rss=1">
<title><![CDATA[Ethics is not just medical ethics]]></title>
<link>http://sti.bmj.com/cgi/content/short/89/4/304?rss=1</link>
<description><![CDATA[ <p>At the very time Nazi doctors were on trial, American doctors, with public funding and official approval, conducted the shockingly immoral research summarised here by Zenilman. While not running for as long as the infamous Tuskegee study in which patients were wrongfully left untreated, this research, even more shockingly, involved deliberately harming people by infecting them with syphilis, gonorrhoea and chancroid. The paper provides a salutary reminder of just how important it is to have regulatory oversight of scientific trials. At the same time, it highlights important questions about the role and limits of informed consent procedures. Informed consent procedures are vital, but it is equally important that we do not exaggerate what they can achieve, and what they explain. While research done without informed consent is wrong, there are wrongs which do not become acceptable by being consented to. Much medical research that was conducted in the past...]]></description>
<dc:creator><![CDATA[Allais, L.]]></dc:creator>
<dc:date>2013-05-17T00:44:44-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2013-051114</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2013-051114</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:title><![CDATA[Ethics is not just medical ethics]]></dc:title>
<prism:publicationDate>2013-06-01</prism:publicationDate>
<prism:section>Commentary</prism:section>
<prism:volume>89</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>304</prism:startingPage>
<prism:endingPage>304</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/89/4/305?rss=1">
<title><![CDATA[Comparison of self-obtained penile-meatal swabs to urine for the detection of C. trachomatis, N. gonorrhoeae and T. vaginalis]]></title>
<link>http://sti.bmj.com/cgi/content/short/89/4/305?rss=1</link>
<description><![CDATA[
<sec><st>Background</st>
<p>Self-obtained penile-meatal swabs and urine specimens have been used for <I>Chlamydia trachomatis</I> (CT), <I>Neisseria gonorrhoeae</I> (NG) and <I>Trichomonas vaginalis</I> (TV) for outreach screening in men.</p>
</sec>
<sec><st>Objective</st>
<p>To compare the sensitivity of self-collected male penile-meatal swabs and urine for the detection of <I>CT</I>, <I>NG</I> and <I>TV</I>.</p>
</sec>
<sec><st>Methods</st>
<p>Matching penile-meatal swabs and urines were collected at home after recruitment to the study; via the internet programme, <A HREF="http://www.iwantthekit.org">http://www.iwantthekit.org</A>. The instructions directed the participant to place the tip of a Copan flocked swab at the meatal opening of the urethra to collect the penile-meatal sample. Two ml of urine was collected after the swab onto a Copan sponge-on-a-shaft collection device. Both swab and urine were placed into individual Aptima transport media tubes and mailed to the laboratory for testing. All specimens were tested for CT and NG using the GenProbe Aptima Combo2 Assay and for TV using GenProbe Aptima Analyte Specific Reagents with TV oligonucleotides.</p>
</sec>
<sec><st>Results</st>
<p>Of 634 men, 86 (13.6%) were positive for CT, 9 (1.4%) were positive for NG and 56 (9.3%) positive for TV. For CT, swab sensitivity was 81/86 (94.2%), and urine sensitivity was 66/86 (76.7%). For NG, swab sensitivity was 9/9 (100%) and urine sensitivity was 8/9 (88.9%). For TV, swab sensitivity was 45/56 (80.4%) and urine sensitivity was 22/56 (39.3%).</p>
</sec>
<sec><st>Conclusions</st>
<p>Self-obtained penile-meatal swabs provided for the detection of more CT, NG and TV, than urine specimens.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Dize, L., Agreda, P., Quinn, N., Barnes, M. R., Hsieh, Y.-H., Gaydos, C. A.]]></dc:creator>
<dc:date>2013-05-17T00:44:44-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2012-050686</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2012-050686</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:subject><![CDATA[Ophthalmology, Chlamydia, Screening (epidemiology), Screening (public health)]]></dc:subject>
<dc:title><![CDATA[Comparison of self-obtained penile-meatal swabs to urine for the detection of C. trachomatis, N. gonorrhoeae and T. vaginalis]]></dc:title>
<prism:publicationDate>2013-06-01</prism:publicationDate>
<prism:section>Clinical</prism:section>
<prism:volume>89</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>305</prism:startingPage>
<prism:endingPage>307</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/89/4/307?rss=1">
<title><![CDATA[Influence of anaerobic conditions on vaginal microbiota recovery from bacterial vaginosis patients]]></title>
<link>http://sti.bmj.com/cgi/content/short/89/4/307?rss=1</link>
<description><![CDATA[ <sec> <p>Bacterial vaginosis (BV) is one of the most common infections in women of reproductive age. Clinical studies have shown an association among BV and abnormal pregnancy, pelvic inflammatory disease and an increased risk of sexually transmitted infections, including HIV.<cross-ref type="bib" refid="R1">1</cross-ref> This disorder was first described in 1914 by Curtis as a &lsquo;white discharge&rsquo; syndrome<cross-ref type="bib" refid="R2">2</cross-ref> and despite the decades of research we have only limited, and clearly not conclusive, evidence of microbial cause of BV, mechanism of disease and effective treatment.</p> <p>The development of molecular techniques such as Denaturing Gradient Gel Electrophoresis (DGGE) and DNA sequencing produced a clearer picture of the complexities of the vaginal microbiota.<cross-ref type="bib" refid="R3">3</cross-ref> It has also become more apparent that none of the microorganisms already isolated from the vagina are likely to be the sole pathogen responsible for BV. Thus, improved knowledge of the relationship between different species of bacteria...]]></description>
<dc:creator><![CDATA[Cereija, T. B., Castro, J., Alves, P., Cerca, N.]]></dc:creator>
<dc:date>2013-05-17T00:44:44-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2013-051100</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2013-051100</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:title><![CDATA[Influence of anaerobic conditions on vaginal microbiota recovery from bacterial vaginosis patients]]></dc:title>
<prism:publicationDate>2013-06-01</prism:publicationDate>
<prism:section>Letter</prism:section>
<prism:volume>89</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>307</prism:startingPage>
<prism:endingPage>307</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/89/4/308?rss=1">
<title><![CDATA[HIV testing for acute medical admissions: evaluation of a pilot study in Leicester, England]]></title>
<link>http://sti.bmj.com/cgi/content/short/89/4/308?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>The 2008 UK National Guidelines for HIV testing recommended HIV testing should be offered to all general medical admissions aged 16&ndash;60 years in high prevalence areas, and that this should be evaluated to ensure this was effective in diagnosing previously undiagnosed HIV.</p>
</sec>
<sec><st>Methods</st>
<p>HIV testing was introduced as a routine test for all patients admitted to the acute medical admissions unit, comparisons were made between the testing rates before, during and after this intervention.</p>
</sec>
<sec><st>Results</st>
<p>The pilot was initiated in August 2009. Prior to the pilot the unit was carrying out 15 tests per month. However, when the pilot was introduced 82 tests were being carried out per month with a total of 10 new diagnoses since the start of the pilot. The proportion of patients tested versus those eligible for testing remained low varying between 6% and 22% month by month. 10 patients we found to be HIV positive with a prevalence of approximately 1%, 10 fold higher than the cut off for cost effectiveness used in the guidelines.</p>
</sec>
<sec><st>Conclusions</st>
<p>Overall the pilot showed that HIV testing could be delivered without the use of extra resources and is acceptable to patients.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Palfreeman, A., Nyatsanza, F., Farn, H., McKinnon, G., Schober, P., McNally, P.]]></dc:creator>
<dc:date>2013-05-17T00:44:44-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2011-050401</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2011-050401</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:subject><![CDATA[Health policy, Editor's choice, Drugs: infectious diseases, HIV/AIDS, HIV / AIDS, HIV infections, Health service research]]></dc:subject>
<dc:title><![CDATA[HIV testing for acute medical admissions: evaluation of a pilot study in Leicester, England]]></dc:title>
<prism:publicationDate>2013-06-01</prism:publicationDate>
<prism:section>Clinical</prism:section>
<prism:volume>89</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>308</prism:startingPage>
<prism:endingPage>310</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/89/4/310?rss=1">
<title><![CDATA[No condoms for prisoners: accumulating risks of HIV, STI but also hepatitis transmission]]></title>
<link>http://sti.bmj.com/cgi/content/short/89/4/310?rss=1</link>
<description><![CDATA[ <sec> <p>Butler <I>et al</I><cross-ref type="bib" refid="R1">1</cross-ref> report convincing results confirming that the availability of HIV prevention tools, such as condoms in prisons, does not increase sexual activity among inmates but rather increases safe sex. These results represent a major step towards negating the widespread belief that the general availability of prevention measures in prisons increases at-risk practices associated with HIV, hepatitis and other sexually transmitted infections (STIs). Indeed, similar ad hoc studies regarding the availability of needles and syringes programmes in prisons (NSPs) showed no increase in injection but an increase in safe injecting practices.<cross-ref type="bib" refid="R2">2</cross-ref> Despite such evidence, NSPs continue to be banned in prisons in several countries.</p> <p>Recommendations by the authors about breaking down the last barriers to condom availability in prisons are particularly significant and timely for several reasons. First, condoms are not always available in prisons and, paradoxically, this is particularly true in countries...]]></description>
<dc:creator><![CDATA[Lorente, N., Zylberman, P., Carrieri, M. P.]]></dc:creator>
<dc:date>2013-05-17T00:44:44-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2013-051080</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2013-051080</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:title><![CDATA[No condoms for prisoners: accumulating risks of HIV, STI but also hepatitis transmission]]></dc:title>
<prism:publicationDate>2013-06-01</prism:publicationDate>
<prism:section>Letter</prism:section>
<prism:volume>89</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>310</prism:startingPage>
<prism:endingPage>310</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/89/4/311?rss=1">
<title><![CDATA[Systematic review examining differences in HIV, sexually transmitted infections and health-related harms between migrant and non-migrant female sex workers]]></title>
<link>http://sti.bmj.com/cgi/content/short/89/4/311?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>To assess the evidence of differences in the risk of HIV, sexually transmitted infections (STI) and health-related behaviours between migrant and non-migrant female sex workers (FSWs).</p>
</sec>
<sec><st>Methods</st>
<p>Systematic review of published peer-reviewed articles that reported data on HIV, STIs or health-related harms among migrant compared with non-migrant FSWs. Studies were mapped to describe their methods and focus, with a narrative synthesis undertaken to describe the differences in outcomes by migration status overall and stratified by country of origin. Unadjusted ORs are presented graphically to describe differences in HIV and acute STIs among FSWs by migration and income of destination country.</p>
</sec>
<sec><st>Results</st>
<p>In general, migrant FSWs working in lower-income countries are more at risk of HIV than non-migrants, but migrants working in higher-income countries are at less risk. HIV prevalence was higher among migrant FSWs from Africa in high-income countries. Migrant FSWs in all countries are at an increased risk of acute STIs. Study designs, definitions of FSWs and recruitment methods are diverse. Behavioural data focussed on sexual risks.</p>
</sec>
<sec><st>Discussion</st>
<p>The lack of consistent differences in risk between migrants and non-migrants highlights the importance of the local context in mediating risk among migrant FSWs. The higher prevalence of HIV among some FSWs originating from African countries is likely to be due to infection at home where HIV prevalence is high. There is a need for ongoing monitoring and research to understand the nature of risk among migrants, how it differs from that of local FSWs and changes over time to inform the delivery of services.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Platt, L., Grenfell, P., Fletcher, A., Sorhaindo, A., Jolley, E., Rhodes, T., Bonell, C.]]></dc:creator>
<dc:date>2013-05-17T00:44:44-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2012-050491</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2012-050491</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:subject><![CDATA[Drugs: infectious diseases, HIV/AIDS, HIV / AIDS, HIV infections, Sex workers]]></dc:subject>
<dc:title><![CDATA[Systematic review examining differences in HIV, sexually transmitted infections and health-related harms between migrant and non-migrant female sex workers]]></dc:title>
<prism:publicationDate>2013-06-01</prism:publicationDate>
<prism:section>Review</prism:section>
<prism:volume>89</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>311</prism:startingPage>
<prism:endingPage>319</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/89/4/320?rss=1">
<title><![CDATA[Point-of-care tests for the diagnosis of Neisseria gonorrhoeae infection: a systematic review of operational and performance characteristics]]></title>
<link>http://sti.bmj.com/cgi/content/short/89/4/320?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>Systematic review of the performance and operational characteristics of point-of-care (POC) tests for the diagnosis of <I>Neisseria gonorrhoeae</I>.</p>
</sec>
<sec><st>Methods</st>
<p>We searched PubMed and Embase until August 2010 using variations of the terms: &lsquo;rapid test&rsquo;, &lsquo;<I>Neisseria gonorrhoeae</I>&rsquo; and &lsquo;evaluation&rsquo;.</p>
</sec>
<sec><st>Results</st>
<p>We identified 100 papers, 14 studies were included; nine evaluated leucocyte esterase (LE) dipsticks and three immunochromatographic strips, and two clinical audits of microscopy were identified. Of the field evaluations the gold standard was nucleic acid amplification technology in six studies and bacterial culture in the other six. In four studies, 50% or more of the patients were symptomatic. The median sensitivity of LE dipsticks was 71% (range 23&ndash;85%), median specificity was 70% (33&ndash;99%), median positive predictive value (PPV) was 19% (5&ndash;40%) and median negative predictive value (NPV) was 95% (56&ndash;99%). One LE study found a sensitivity of 23% overall, increasing to 75% in symptomatic women. LE dipsticks mostly involved three steps and took under 2&nbsp;min. The median sensitivity of immunochromatographic tests (ICT) was 70% (60&ndash;94%), median specificity was 96% (89&ndash;97%), median PPV was 56% (55&ndash;97%) and median NPV was 93% (92&ndash;99%). Immunochromatic strips involved five to seven steps and took 15&ndash;30&nbsp;min. Specificity of microscopy ranged from 38% to 89%.</p>
</sec>
<sec><st>Conclusions</st>
<p>ICT and LE tests had similar sensitivities, but sensitivity results may be overestimated as largely symptomatic patients were included in some studies. ICT had a higher specificity in women than LE tests. The findings highlight the need for improved POC tests for diagnosis of <I>N gonorrhoeae</I> and more standardised evaluations.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Watchirs Smith, L. A., Hillman, R., Ward, J., Whiley, D. M., Causer, L., Skov, S., Donovan, B., Kaldor, J., Guy, R.]]></dc:creator>
<dc:date>2013-05-17T00:44:44-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2012-050656</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2012-050656</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:subject><![CDATA[Gonorrhoea, Clinical diagnostic tests, Internet]]></dc:subject>
<dc:title><![CDATA[Point-of-care tests for the diagnosis of Neisseria gonorrhoeae infection: a systematic review of operational and performance characteristics]]></dc:title>
<prism:publicationDate>2013-06-01</prism:publicationDate>
<prism:section>Review</prism:section>
<prism:volume>89</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>320</prism:startingPage>
<prism:endingPage>326</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/89/4/327?rss=1">
<title><![CDATA[Knowledge of human papillomavirus and cervical cancer among young women recruited using a social networking site]]></title>
<link>http://sti.bmj.com/cgi/content/short/89/4/327?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>Human papillomavirus (HPV) is the commonest sexually transmitted infection. Despite the significant morbidity and mortality associated with HPV-related diseases, previous studies have demonstrated low HPV knowledge in the general population. The objectives of this study were to assess knowledge of cervical cancer and HPV among young women and investigate predictors of high knowledge.</p>
</sec>
<sec><st>Methods</st>
<p>Female subjects, aged 16&ndash;25&nbsp;years living in Victoria, Australia, were recruited using targeted advertising on Facebook from May to September 2010. A web-based questionnaire was used in a cross-sectional pilot study for a large longitudinal study on women's health, The Young Female Health Initiative.</p>
</sec>
<sec><st>Results</st>
<p>A total of 278 women completed the questionnaire. The geographic region, indigenous status and socio-economic status of participants were representative of the target population. Overall, 63% knew what HPV was, but only 48% knew it was a common virus. Predictors of high HPV knowledge on multivariate analyses were older age (adjusted OR (aOR) 2.78, 95% CI 0.77 to 10.04), higher socio-economic status (aOR 1.39, 95% CI 0.66 to 2.95), being Australian-born (aOR 3.10, 95% CI 1.15 to 8.36), older age at first vaginal intercourse (aOR 1.84, 95% CI 0.66 to 5.14), awareness of HPV vaccines (aOR 2.16, 95% CI 0.68 to 6.85) and chlamydia (aOR 2.57, 95% CI 1.11 to 5.94), and self-reported HPV vaccination status (aOR 1.83, 95% CI 0.76 to 4.41).</p>
</sec>
<sec><st>Conclusions</st>
<p>HPV and cervical cancer knowledge among participants were relatively high compared with other studies conducted both worldwide and in Australia. However, deficits in knowledge exist and warrant address in educational initiatives.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Gunasekaran, B., Jayasinghe, Y., Fenner, Y., Moore, E. E., Wark, J. D., Fletcher, A., Tabrizi, S. N., Garland, S. M.]]></dc:creator>
<dc:date>2013-05-17T00:44:44-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2012-050612</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2012-050612</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, Drugs: infectious diseases, Vaccination / immunisation, Cervical cancer, Gynecological cancer, Vulvovaginal disorders]]></dc:subject>
<dc:title><![CDATA[Knowledge of human papillomavirus and cervical cancer among young women recruited using a social networking site]]></dc:title>
<prism:publicationDate>2013-06-01</prism:publicationDate>
<prism:section>Epidemiology</prism:section>
<prism:volume>89</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>327</prism:startingPage>
<prism:endingPage>329</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/89/4/330?rss=1">
<title><![CDATA[Concurrent sexual partnerships among female sex workers and their non-commercial male partners in Tijuana and Ciudad Juarez, Mexico]]></title>
<link>http://sti.bmj.com/cgi/content/short/89/4/330?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>To investigate the prevalence and correlates of concurrent (overlapping) sexual partnerships among female sex workers (FSWs) and their non-commercial male partners in two Mexico&ndash;US border cities.</p>
</sec>
<sec><st>Methods</st>
<p>A cross-sectional survey of FSWs and their non-commercial male partners was conducted in Tijuana and Ciudad Ju&aacute;rez, Mexico (2010&ndash;2011). Eligible FSWs and verified non-commercial partners were aged &ge;18&nbsp;years; FSWs had ever used hard drugs (lifetime) and recently exchanged sex for money, drugs or other goods (past month). Participants underwent baseline questionnaires obtaining dates of sex and condom use with &le;5 other recurring partners, including FSWs&rsquo; regular clients. These dates were compared with dates of sex with enrolled study partners to determine overlap (ie, &lsquo;recurring&rsquo; concurrency). Bivariate probit regression identified recurring concurrency correlates.</p>
</sec>
<sec><st>Results</st>
<p>Among 428 individuals (214 couples), past-year recurring concurrency prevalence was 16% and was higher among women than their non-commercial male partners (26% vs 6%). In 10 couples (5%), both partners reported recurring concurrency. The majority of couples (64%) always had unprotected sex, and most of the individuals (70%) with recurring concurrency &lsquo;sometimes&rsquo; or &lsquo;never&rsquo; used condoms with their concurrent partners. Recurring concurrency was positively associated with FSWs&rsquo; income, men's caballerismo (a form of traditional masculinity) and men's belief that their FSW partners had sexually transmitted infections (STIs).</p>
</sec>
<sec><st>Conclusions</st>
<p>Recurring concurrency, representing sustained periods of overlapping partnerships in which unprotected sex was common, should be addressed by couple-based STI prevention interventions.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Robertson, A. M., Syvertsen, J. L., Rangel, M. G., Staines, H. S., Morris, M., Patterson, T. L., Ulibarri, M. D., Strathdee, S. A.]]></dc:creator>
<dc:date>2013-05-17T00:44:44-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2012-050693</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2012-050693</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:subject><![CDATA[Reproductive medicine, Condoms, Sex workers]]></dc:subject>
<dc:title><![CDATA[Concurrent sexual partnerships among female sex workers and their non-commercial male partners in Tijuana and Ciudad Juarez, Mexico]]></dc:title>
<prism:publicationDate>2013-06-01</prism:publicationDate>
<prism:section>Epidemiology</prism:section>
<prism:volume>89</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>330</prism:startingPage>
<prism:endingPage>332</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/89/4/333?rss=1">
<title><![CDATA[HTLV-1 cosmopolitan and HTLV-2 subtype b among pregnant women of non-endemic areas of Argentina]]></title>
<link>http://sti.bmj.com/cgi/content/short/89/4/333?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>The objective of this study was to estimate the prevalence of human T cell lymphotropic virus (HTLV)-1/2, HIV-1, hepatitis B virus (HBV), <I>Trypanosoma cruzi</I>, <I>Treponema pallidum</I> and <I>Toxoplasma gondii</I> infections and to identify the subtypes/subgroups of HTLV-1/2 among pregnant women (PW) from non-endemic provinces of Argentina.</p>
</sec>
<sec><st>Methods</st>
<p>Methods A total of 2403 samples were screened for HTLV-1/2 and confirmed by western blot and PCR. The long terminal repeat (LTR) of HTLV-1 and HTLV-2 were amplified. Phylogenetic analysis was performed by Neighbour Joining by using molecular evolutionary genetics analysis (MEGA) 4.0.</p>
</sec>
<sec><st>Results</st>
<p>Among a total of 2403 PW studied, 6 (0.25%) tested positive for HTLV-1/2 (3 HTLV-1 (0.12%) and 3 HTLV-2 (0.12%)). The total prevalence when distributed by province was 0.3% (3/804) for Buenos Aires (BA), 0.4% (1/241) for BA surroundings, 0.1% (1/707) for Neuquen and 1.0% (1/95) for Ushuaia. In San Juan, no PW were HTLV-1/2 positive. The prevalence was similar when compared with rates among blood donors of the same areas and years. The phylogenetic analysis classified one sequence as HTLV-1 aA and one as HTLV-2b. The prevalence of HIV-1, HBV, T cruzi, T pallidum and T gondii was 0.6%, 0.2%, 1.4%, 1.2% and 20.9%, respectively. One case of HTLV-1/HIV-1 and one of HTLV-2/HIV-1 co-infection were detected.</p>
</sec>
<sec><st>Conclusions</st>
<p>HTLV-1/2, which have been associated with different diseases, are circulating among PW of Argentina, even in non-endemic areas. Therefore, testing should be recommended in women who have risk factors for these infections given that the majority of HTLV-1/2 mother to child transmission can be prevented by the avoidance of breast feeding.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Berini, C. A., Delfino, C., Torres, O., Garcia, G., Espejo, R., Pianciola, L., Juarez, M., Arribere, G., Nadal, M., Eirin, M. E., Biglione, M. M.]]></dc:creator>
<dc:date>2013-05-17T00:44:44-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2012-050594</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2012-050594</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:subject><![CDATA[Liver disease, Drugs: infectious diseases, Hepatitis and other GI infections, HIV/AIDS, Travel medicine, Tropical medicine (infectious diseases), Pregnancy, Reproductive medicine, Child health, Hepatitis (sexual health), HIV / AIDS, HIV infections]]></dc:subject>
<dc:title><![CDATA[HTLV-1 cosmopolitan and HTLV-2 subtype b among pregnant women of non-endemic areas of Argentina]]></dc:title>
<prism:publicationDate>2013-06-01</prism:publicationDate>
<prism:section>Epidemiology</prism:section>
<prism:volume>89</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>333</prism:startingPage>
<prism:endingPage>335</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/89/4/336?rss=1">
<title><![CDATA[Coverage, context and targeted prevention: optimising our impact]]></title>
<link>http://sti.bmj.com/cgi/content/short/89/4/336?rss=1</link>
<description><![CDATA[
<p>Development of efficacious interventions is only the first step in achieving population level impact. Efficacious interventions impact infection levels in the population only if they are implemented at the right scale. Coverage must be prioritised across subpopulations based on the diversity and clustering of infections and risk in society, and expanded rapidly without delay. It is important to prioritise those who are most likely to transmit infection first.</p>
]]></description>
<dc:creator><![CDATA[Aral, S. O., Cates, W.]]></dc:creator>
<dc:date>2013-05-17T00:44:44-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2012-050707</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2012-050707</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:title><![CDATA[Coverage, context and targeted prevention: optimising our impact]]></dc:title>
<prism:publicationDate>2013-06-01</prism:publicationDate>
<prism:section>Programme science</prism:section>
<prism:volume>89</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>336</prism:startingPage>
<prism:endingPage>340</prism:endingPage>
</item>
<item rdf:about="http://sti.bmj.com/cgi/content/short/89/4/340?rss=1">
<title><![CDATA[Sexual Health: A Public Health Perspective]]></title>
<link>http://sti.bmj.com/cgi/content/short/89/4/340?rss=1</link>
<description><![CDATA[ <p>&lsquo;Sexual Health: A Public Health Perspective&rsquo; is a fantastic new addition to the sexual health literature. The book covers all the topics you would want to see in a book on sexual health (ie, sexually transmitted infections (STIs), unplanned pregnancies, high-risk groups, interventions, etc), but goes beyond the basics to cover topics less commonly discussed (but much needed), such as sexual violence, sexual function, sexual pleasure, sexual satisfaction and communication issues.</p> <p>The authors adopt a social constructionist perspective on sexual behaviour, highlighting the importance of considering the social determinants of sexual behaviour, and the impact social and historical contexts have on public health efforts to improve sexual health.</p> <p>Chapters 2&ndash;5 discuss a comprehensive set of sexual health outcomes of sexual activity, including STIs, unplanned pregnancies, sexual violence, sexual function, sexual pleasure and sexual satisfaction.</p> <p>Chapters 6&ndash;10 look at high-risk populations (ie, young people, men who have sex with men,...]]></description>
<dc:creator><![CDATA[Hobbs, L.]]></dc:creator>
<dc:date>2013-05-17T00:44:44-07:00</dc:date>
<dc:identifier>info:doi/10.1136/sextrans-2013-051085</dc:identifier>
<dc:identifier>hwp:master-id:sextrans;sextrans-2013-051085</dc:identifier>
<dc:publisher>The Medical Society for the Study of Venereal Disease</dc:publisher>
<dc:title><![CDATA[Sexual Health: A Public Health Perspective]]></dc:title>
<prism:publicationDate>2013-06-01</prism:publicationDate>
<prism:section>Book Review</prism:section>
<prism:volume>89</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>340</prism:startingPage>
<prism:endingPage>340</prism:endingPage>
</item>
</rdf:RDF>